Clinical Trial Update: Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence [Phase 3]

View source ↗

Summary

Phase 3 trial comparing patent foramen ovale closure versus anticoagulants and antiplatelet therapy to prevent stroke recurrence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Aneurysm
• Migraine
• Patent Foramen Ovale
• Stroke

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Ischemic Stroke, Patent Foramen Ovale | Phase 3 | Status: COMPLETED